AEON Biopharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DAUNTLESS INVESTMENT GROUP, LLC | 02/17/2026 | 2.13 M | $1.32 M | 89.50% | 21.49% |
| VANGUARD GROUP INC | 01/29/2026 | 100.33 K | $110.37 K | 1.79% | 1.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 60.13 K | $66.15 K | 27.75% | 0.61% |
| XTX TOPCO LTD | 02/17/2026 | 56.85 K | $62.54 K | 251.76% | 0.57% |
| BLUE OWL CAPITAL HOLDINGS LP | 02/20/2026 | 43.40 K | $47.74 K | 2.46% | 0.44% |
| LAIRD NORTON TRUST COMPANY, LLC | 02/17/2026 | 15.00 K | $16.50 K | 100.00% | 0.15% |
| TWO SIGMA SECURITIES, LLC | 02/17/2026 | 13.18 K | $14.50 K | 100.00% | 0.13% |
| CITADEL ADVISORS LLC | 02/17/2026 | 11.64 K | $12.81 K | 100.00% | 0.12% |
| UBS GROUP AG | 01/29/2026 | 4.05 K | $4.46 K | 239.93% | 0.04% |
| BLACKROCK, INC. | 02/12/2026 | 2.83 K | $3.12 K | 0.00% | 0.03% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 2.38 K | $2.62 K | 0.25% | 0.02% |
| WOLFF WIESE MAGANA LLC | 01/14/2026 | 567 | $624 | 746.27% | 0.01% |
| DUPONT CAPITAL MANAGEMENT CORP | 01/26/2026 | 170 | $187 | 0.00% | 0.00% |
| MORGAN STANLEY | 02/13/2026 | 150 | $165 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 105 | $116 | -0.94% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/12/2026 | 100 | $110 | 0.00% | 0.00% |
| GHP INVESTMENT ADVISORS, INC. | 01/27/2026 | 95 | $105 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 90 | $99 | 0.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 02/13/2026 | 58 | $64 | 0.00% | 0.00% |
| CIBC PRIVATE WEALTH GROUP, LLC | 02/12/2026 | 33 | $36 | 0.00% | 0.00% |
| METEORA CAPITAL, LLC | 02/17/2026 | 4 | $4 | 100.00% | 0.00% |
| DANSKE BANK A/S | 02/02/2026 | 1 | $1 | 0.00% | 0.00% |
| BARCLAYS PLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| STONEX GROUP INC. | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
AEON Biopharma Inc. institutional Ownership - FAQ's
During the previous two years, 35 institutional investors and hedge funds held shares of AEON Biopharma Inc.. The most heavily invested institutionals were:
Formidable Asset Management, LLC: 20,024
JANE STREET GROUP, LLC: 16,376
VANGUARD FIDUCIARY TRUST CO: 14,702
LPL Financial LLC: 11,507
UBS Group AG: 4,182
Steward Partners Investment Advisory, LLC: 1,100
24.62% of AEON Biopharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 6.46 M shares in the last 24 months. This purchase volume represents approximately $6.78 M in transactions.